The mechanism by which the CYP3A4 status influences the occurrence of irinotecan-induced diarrhoea remains elusive, as the metabolites of irinotecan produced in this pathway do not display cytotoxic activity. This evidence concerns the gene CYP3A4 and Diarrhea.